Trump, drug prices and White House
Digest more
In this week’s edition of InnovationRx, we look at the Haitian immigrant who built a $6 billion company treating brain diseases, the drugs RFK Jr. may target after Tylenol, Northwell’s new CEO, and more.
TrumpRx will allow users to find pharmaceutical drugs and purchase them directly from the manufacturers. Medicare director Chris Klomp said the drugs will “often” be sold at the full most-favored-nation price, and “always at lower prices than currently available.”
While President Donald Trump announced on Tuesday that Pfizer, one of the leading pharmaceutical companies, had agreed to lower its prices for prescription drugs offered through Medicaid, he also revealed his administration's goal of launching a "TrumpRx" website.
Pfizer's concessions look benign on its own earnings — but for peers, the deal is a red flag. UnitedHealth faces PBM margin risk, Eli Lilly gets a short-term pop with a long-term leash, and CVS may see its retail and PBM dominance chipped away.
President Trump unveiled the first of what he says will be many deals with drugmakers to cut prices. For the 90% of Americans who have health insurance, it’s unlikely to save much money, [Joseph Walke